Unlearn.AI offers clinical trials by using digital twinsβAI-generated models that predict a patient’s health outcomes. These digital twins reduce the number of participants needed, shortening enrollment time, and increasing the power of early-stage studies. It helps researchers make faster, more confident decisions in areas like neuroscience, immunology, and metabolic diseases.
π Overview of Unlearn.AI
Founding Year
2017
Estimated Funding
Size
$0000
Locations
Primary Industry
π About Unlearn.AI
π° Recent Investors of Unlearn.AI
Altimeter Capital Management, Insight Partners, Investor
π Companies Similar to Unlearn.AI
Β© 2025 Bot Memo. All Rights Reserved.
